A. Kaźmierczak

Expression of the BIRC5 gene in the presence of adalimumab in normal human dermal fibroblasts (NHDF)

D. Wcisło-Dziadecka, Nikola Zmarzły, A. Kaźmierczak, 2018 .

The Transcriptional Activity of LAMP3 Gene Involved in Autophagocytosis in Colorectal Cancer LAMP3 Expression in Colorectal Cancer

M. Muc-Wierzgoń, K. Walkiewicz, U. Mazurek, 2017 .

Psoriasis Treatment Changes the Expression Profile of Selected Caspases and their Regulatory MicroRNAs

Marek J. Łos, J. Gola, J. Hybiak, 2018, Cellular Physiology and Biochemistry.

Newer treatments of psoriasis regarding IL‐23 inhibitors, phosphodiesterase 4 inhibitors, and Janus kinase inhibitors

K. Bebenek, L. Brzezińska-Wcisło, D. Wcisło-Dziadecka, 2017, Dermatologic therapy.

Are new variants of psoriasis therapy (IL‐17 inhibitors) safe?

L. Brzezińska-Wcisło, D. Wcisło-Dziadecka, M. Zbiciak-Nylec, 2019, International journal of dermatology.

Health from nature – Nigella sativa in cosmetics and medicinal products

D. Wcisło-Dziadecka, Nikola Zmarzły, A. Kaźmierczak, 2018 .

Body mass index and body surface area in scleroderma patients

L. Brzezińska-Wcisło, Z. Brzoza, D. Wcisło-Dziadecka, 2018, Journal of the European Academy of Dermatology and Venereology : JEADV.

Values of body mass index (BMI) and body surface area (BSA) in patients with psoriatic arthritis treated with adalimumab: Preliminary report

Z. Brzoza, D. Wcisło-Dziadecka, K. Adamczyk, 2018, Dermatologic therapy.

The influence of adalimumab on the expression profile of mRNAs and miRNAs related to the IL‐12 and IL‐23 signal paths

J. Gola, D. Wcisło-Dziadecka, C. Kruszniewska-Rajs, 2019, Journal of the European Academy of Dermatology and Venereology.